Fernand Labrie

CONGRESSES & CONFERENCES

Page 3 of 27, showing 20 records out of 533 total, starting on record 41, ending on 60

Event Where When
Title
International Society of Gynecological Endocrinology Symposium on “The role of androgens in female sexual function” – “Current knowledge of androgens in breast cancer”, Florence, March 2006. 2006
Menopause Conference, Center for Business Intelligence, Menopause Pharmacotherapeutic Development – Current Trends, Challenges and Scientific Advances for Drug Development for Menopause and Related Is 2006
Les Nouvelles Approches au Bien Vieillir des Femmes – Symposium Canada-France “Femmes et veillessement – rôle des hormones », Nice, March 2006. 2006
Biomedex 2006 – Success in technology transfer: the first 18 months – Proof of concept, Montreal, May 2006. 2006
Androgen Excess Society – 4th Annual Meeting “Role of the adrenal in androgen excess in women”, Boston, June 2006. 2006
2006 Prostate Cancer Update at the occasion of Dacapeptyl’s 20th Anniversary, “The multiple intracrine targets in the prostate: opportunities and challenges”, Budapest, September 2006 2006
Gunma University Urological meeting, “The key role of combined androgen blockade in prostate cancer”, Tagasaki, October 2006 2006
The Endocrine Society’s 88th Annual meeting, meeting of the Androgen Excess Society “Physiology and role of androgen in women”, Boston, June 2006 2006
International Symposium –Scientific Advisory Board and Faculty, 8th International Symposium on GnRH analogues in cancer and human reproduction, Salzburg, Austria, February 2005. 2005
10th Yearly meeting of the International Menopause Forum Tuohilampi (IMFT) “What about the importance of androgens in women”, Hamburg, June 2005 2005
7th European Congress of Endocrinology – HRT-clinical management « SERMs and future perspectives », Göteborg, September 2005. 2005
International Solamer Symposium « Biologie moléculaire, génomique et nouvelle médecine de la ménopause », Québec, (octobre 2005) 2005
Pleanary lecture: Symposium of FMC SOGC/AOGQ/SOLAMER – Quel sera l’impact de la biologie moléculaire dans notre pratique? Québec, October 2005. 2005
The WADA Symposium on Gene Doping, “DHEA is an anabolic steroid like testosterone and THG”, Stockholm, December 2005. 2005
2005 Prostate Cancer Symposium of the American Society of Clinical Oncology (ASCO), the American Society of Therapeutic Radiology and Oncology (ASTRO), the Society of Urologic Oncology (SUO) and the P 2005
International Menopause Forum Tuohilampi, “The role of androgens for the female health and for the breast“, Vienne (June 2004) 2004
Sex Steroids: An Update of Estrogen and Progesterone Actions – Role in Cancer, Ageing and Reproductive Medicine, Recent Data from Research to Clinical Practice, “Third Generation SERMs?” Montpellier ( 2004
4e World Conférence of Science Journalists (WCS) Genomics of Common diseases/Génomique et maladies, « Genome of Hormone-Sensitive Diseases », Montréal (Octobre 2004) 2004
3rd International Symposium, "The Science and Technology of Skin Engineering" - "Hormonal Equipment in Skin In Vitro", “The skin as an important site of local formation and action of sex steroids”, La 2004
Women’s Health Symposium, 50th Annual Meeting of the Canadian Fertility and Andrology Society, “SERMs as Part of Novel HRT“, Jasper (November 2004) 2004
<< previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 next >>

Biography  |  Publications  |  Scientific Conferences  |  Selected Slide Presentations  |  Awards